U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915232) titled 'A Study to Assess Pregnancy, Neonatal and Infant Outcomes in Participants Exposed to Nipocalimab' on Oct. 30.
Brief Summary: The purpose of this study is to find out how often:
* Pregnancy problems, complications in mothers, and health issues in newborn babies occurred in participants who took nipocalimab just before or during pregnancy.
* Serious infections occur in newborns and infants born to participants who took nipocalimab just before or during pregnancy.
* Babies are born with major birth defects (not related to chromosomes) in pregnancies where nipocalimab was taken just before or during pregnancy.
Study Start Date: Nov. ...